Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chimeric Peptides from Californiconus californicus and Heterodontus francisci with Antigen-Binding Capacity: A Conotoxin Scaffold to Create Non-Natural Antibodies (NoNaBodies).
Dueñas S, Escalante T, Gasperin-Bulbarela J, Bernáldez-Sarabia J, Cervantes-Luévano K, Jiménez S, Sánchez-Campos N, Cabanillas-Bernal O, Valdovinos-Navarro BJ, Álvarez-Lee A, De León-Nava MA, Licea-Navarro AF. Dueñas S, et al. Among authors: cervantes luevano k. Toxins (Basel). 2023 Apr 4;15(4):269. doi: 10.3390/toxins15040269. Toxins (Basel). 2023. PMID: 37104207 Free PMC article.
The Diversified O-Superfamily in Californiconus californicus Presents a Conotoxin with Antimycobacterial Activity.
Bernáldez-Sarabia J, Figueroa-Montiel A, Dueñas S, Cervantes-Luévano K, Beltrán JA, Ortiz E, Jiménez S, Possani LD, Paniagua-Solís JF, Gonzalez-Canudas J, Licea-Navarro A. Bernáldez-Sarabia J, et al. Among authors: cervantes luevano k. Toxins (Basel). 2019 Feb 20;11(2):128. doi: 10.3390/toxins11020128. Toxins (Basel). 2019. PMID: 30791616 Free PMC article.
Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern.
Valdovino-Navarro BJ, Dueñas S, Flores-Acosta GI, Gasperin-Bulbarela J, Bernaldez-Sarabia J, Cabanillas-Bernal O, Cervantes-Luevano KE, Licea-Navarro AF. Valdovino-Navarro BJ, et al. Among authors: cervantes luevano ke. Int J Mol Sci. 2022 Oct 14;23(20):12267. doi: 10.3390/ijms232012267. Int J Mol Sci. 2022. PMID: 36293124 Free PMC article.
Neutralizing antibodies levels are increased in individuals with heterologous vaccination and hybrid immunity with Ad5-nCoV in the north of Mexico.
Cervantes-Luevano K, Espino-Vazquez AN, Flores-Acosta G, Bernaldez-Sarabia J, Cabanillas-Bernal O, Gasperin-Bulbarela J, Gonzalez-Sanchez R, Comas-Garcia A, Licea-Navarro AF. Cervantes-Luevano K, et al. PLoS One. 2022 Jun 24;17(6):e0269032. doi: 10.1371/journal.pone.0269032. eCollection 2022. PLoS One. 2022. PMID: 35749390 Free PMC article.
Cationic versus anionic core-shell nanogels for transport of cisplatin to lung cancer cells.
Gonzalez-Urias A, Zapata-Gonzalez I, Licea-Claverie A, Licea-Navarro AF, Bernaldez-Sarabia J, Cervantes-Luevano K. Gonzalez-Urias A, et al. Among authors: cervantes luevano k. Colloids Surf B Biointerfaces. 2019 Oct 1;182:110365. doi: 10.1016/j.colsurfb.2019.110365. Epub 2019 Jul 15. Colloids Surf B Biointerfaces. 2019. PMID: 31344612
Treatment with metformin glycinate reduces SARS-CoV-2 viral load: An in vitro model and randomized, double-blind, Phase IIb clinical trial.
Ventura-López C, Cervantes-Luevano K, Aguirre-Sánchez JS, Flores-Caballero JC, Alvarez-Delgado C, Bernaldez-Sarabia J, Sánchez-Campos N, Lugo-Sánchez LA, Rodríguez-Vázquez IC, Sander-Padilla JG, Romero-Antonio Y, Arguedas-Núñez MM, González-Canudas J, Licea-Navarro AF. Ventura-López C, et al. Among authors: cervantes luevano k. Biomed Pharmacother. 2022 Aug;152:113223. doi: 10.1016/j.biopha.2022.113223. Epub 2022 Jun 2. Biomed Pharmacother. 2022. PMID: 35709650 Free PMC article. Clinical Trial.
14 results